Schedule 13G ownership disclosure
CYMABAY THERAPEUTICS INC
Security class unavailable · CUSIP: 23257D103
Event date: 2017-11-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 1.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-17-056330
- Form type
- SC 13G
- Filer
- CymaBay Therapeutics, Inc.
- CIK
- CIK 1042074
- Filed
- Nov 06, 2017
- Reporting period
- Nov 01, 2017
- Description
- Schedule 13G beneficial ownership